English

AMERIMMUNE PHARMACEUTICALS INC

EDGAR

Filing (10QSB) · filed 2003-02-18

24 filing records in this dataset, filed from 1998-01-22 to 2003-02-18. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

1998-12-31 · USD

Exact inputs and evidence

Revenue: 0 USD Source

Operating cash flow

-295 thousand USD

1998-12-31 · USD

Exact inputs and evidence

Operating Cash Flow: -299640 USD Source
Operating Cash Flow: -4784 USD Source

Cash and cash equivalents: 2.16 thousand USD 2002-12-31 Source
Exact value

2163 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

0 USD

1998-01-01 – 1998-12-31

Exact inputs and evidence

Revenue: 0 USD · 1997-04-01 – 1998-03-31 Source
Revenue: 0 USD · 1997-04-01 – 1997-12-31 Source
Revenue: 0 USD · 1998-04-01 – 1998-06-30 Source
Revenue: 0 USD · 1998-07-01 – 1998-09-30 Source
Revenue: 0 USD · 1998-10-01 – 1998-12-31 Source

Capital expenditure

1.01 thousand USD

2002-01-01 – 2002-12-31

Exact inputs and evidence

Capital expenditure: 1006 USD · 2001-04-01 – 2002-03-31 Source
Capital expenditure: 0 USD · 2001-04-01 – 2001-12-31 Source
Capital expenditure: 0 USD · 2002-04-01 – 2002-06-30 Source
Capital expenditure: 0 USD · 2002-04-01 – 2002-09-30 Source
Capital expenditure: 0 USD · 2002-04-01 – 2002-06-30 Source
Capital expenditure: 0 USD · 2002-04-01 – 2002-12-31 Source
Capital expenditure: 0 USD · 2002-04-01 – 2002-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2003-02-18.

Financial data available through: 2002-03-31.

Coverage by financial measure

Revenue: 2 of 11 periods available· newest 1998-03-31
Operating income: 4 of 11 periods available· newest 2002-03-31
Net income: 6 of 11 periods available· newest 2002-03-31
Operating cash flow: 5 of 11 periods available· newest 2002-03-31
Capital expenditure: 3 of 11 periods available· newest 2002-03-31
Total assets: 6 of 11 periods available· newest 2002-03-31
Total liabilities: 1 of 11 periods available· newest 1998-03-31
Current assets: 6 of 11 periods available· newest 2002-03-31
Current liabilities: 6 of 11 periods available· newest 2002-03-31
Cash and cash equivalents: 6 of 11 periods available· newest 2002-03-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
−USD 476,813

Prior period

−USD 1.16 million

2000-04-01 – 2001-03-31
Current period

−USD 1.64 million

2001-04-01 – 2002-03-31

Exact inputs and evidence

-1640622 − -1163809 = -476813 USD

-1163809 USD · 2000-04-01 – 2001-03-31
Inspect prior input Prior source
-1640622 USD · 2001-04-01 – 2002-03-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · AMERIMMUNE PHARMACEUTICALS INC · 2002-03-31 AMERIMMUNE PHARMACEUTICALS INC (edgar:818808) Year-over-year change in Net income: -476813 USD Concept: fundies:NetIncome Period: 2001-04-01 to 2002-03-31 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/818808?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -1640622 USD (2001-04-01 to 2002-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818808/0001017951-02-000322.txt#2569 Input fundies:NetIncome: -1163809 USD (2000-04-01 to 2001-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818808/0001017951-02-000322.txt#2569
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 60,171

Prior period

−USD 924,733

2000-04-01 – 2001-03-31
Current period

−USD 864,562

2001-04-01 – 2002-03-31

Exact inputs and evidence

-864562 − -924733 = 60171 USD

-924733 USD · 2000-04-01 – 2001-03-31
Inspect prior input Prior source
-864562 USD · 2001-04-01 – 2002-03-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · AMERIMMUNE PHARMACEUTICALS INC · 2002-03-31 AMERIMMUNE PHARMACEUTICALS INC (edgar:818808) Year-over-year change in Operating cash flow: 60171 USD Concept: fundies:OperatingCashFlow Period: 2001-04-01 to 2002-03-31 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/818808?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -864562 USD (2001-04-01 to 2002-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818808/0001017951-02-000322.txt#2602 Input fundies:OperatingCashFlow: -924733 USD (2000-04-01 to 2001-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818808/0001017951-02-000322.txt#2602
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+115.9%

Prior period

USD 466

2000-04-01 – 2001-03-31
Current period

USD 1,006

2001-04-01 – 2002-03-31

Exact inputs and evidence

1006 − 466 = 540 USD

466 USD · 2000-04-01 – 2001-03-31
Inspect prior input Prior source
1006 USD · 2001-04-01 – 2002-03-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · AMERIMMUNE PHARMACEUTICALS INC · 2002-03-31 AMERIMMUNE PHARMACEUTICALS INC (edgar:818808) Year-over-year change in Capital expenditure: 540 USD Concept: fundies:CapitalExpenditure Period: 2001-04-01 to 2002-03-31 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/818808?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 1006 USD (2001-04-01 to 2002-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818808/0001017951-02-000322.txt#2607 Input fundies:CapitalExpenditure: 466 USD (2000-04-01 to 2001-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818808/0001017951-02-000322.txt#2607
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

1998 1997-04-01 – 1998-03-31

Revenue USD 0
Operating costs Derived Unavailable An input is unavailable.
Operating income Unavailable An input is unavailable.
Tax, interest and other Derived Unavailable An input is unavailable.
Net income −USD 6,957

Cash

Operating cash flow −USD 5,461
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1997 Not shown: operating income or net income is not reported.
1998 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1997 1996-04-01 – 1997-03-31	0	Unavailable	Unavailable	Unavailable	-20271	Unavailable	Source 1996-04-01 – 1997-03-31: 0 USD Inspect Revenue Open source 1996-04-01 – 1997-03-31: -20271 USD Inspect Net Income Open source 1996-04-01 – 1997-03-31: 0 USD Inspect Operating Cash Flow Open source
1998 1997-04-01 – 1998-03-31	0	Unavailable	Unavailable	Unavailable	-6957	Unavailable	Source 1997-04-01 – 1998-03-31: 0 USD Inspect Revenue Open source 1997-04-01 – 1998-03-31: -6957 USD Inspect Net Income Open source 1997-04-01 – 1998-03-31: -5461 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 0 1998

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19971997-03-31	Revenue	0	Revenue: 0 Open source
19981998-03-31	Revenue	0	Revenue: 0 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19971997-03-31	Year over year	No prior comparable period	Revenue: 0 Open source
19981998-03-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
1997-03-31	Operating margin	Not reported	Revenue: 0 Open source
1998-03-31	Operating margin	Not reported	Revenue: 0 Open source
19971997-03-31	Net margin	Not reported	Net Income: -20271 Open source Revenue: 0 Open source
19981998-03-31	Net margin	Not reported	Net Income: -6957 Open source Revenue: 0 Open source
19971997-03-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: 0 Open source
19981998-03-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -5461 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -5.5K 1998

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19971997-03-31	Operating cash flow	0	Operating Cash Flow: 0 Open source
19981998-03-31	Operating cash flow	-5461	Operating Cash Flow: -5461 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19971997-03-31	Free cash flow	Unavailable	Operating Cash Flow: 0 Open source
19981998-03-31	Free cash flow	Unavailable	Operating Cash Flow: -5461 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1997-03-31	Liabilities / assets	Not reported	Total Assets: 0 Open source
19981998-03-31	Liabilities / assets	Not reported	Total Liabilities: 19151 Open source Total Assets: 0 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0× 1998

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
19971997-03-31	Current assets / current liabilities	0×	Current Assets: 0 Open source Current Liabilities: 12194 Open source
19981998-03-31	Current assets / current liabilities	0×	Current Assets: 0 Open source Current Liabilities: 19151 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1997 1996-04-01 – 1997-03-31	−USD 20,271 Exact value Exact value: -20271 USD 1996-04-01 – 1997-03-31: -20271 USD Inspect Net Income Open source Share or cite Citation for Net Income · AMERIMMUNE PHARMACEUTICALS INC · 1997-03-31 AMERIMMUNE PHARMACEUTICALS INC (edgar:818808) Net Income: -20271 USD Concept: fundies:NetIncome Period: 1996-04-01 to 1997-03-31 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/818808/explain?concept=fundies%3ANetIncome&period=1997-03-31&surface=latest&period_type=duration&start=1996-04-01&unit=USD&dimensions= Input fundies:NetIncome: -20271 USD (1996-04-01 to 1997-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818808/0001011034-98-000088.txt#1201 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 1996-04-01 – 1997-03-31: 0 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AMERIMMUNE PHARMACEUTICALS INC · 1997-03-31 AMERIMMUNE PHARMACEUTICALS INC (edgar:818808) Operating Cash Flow: 0 USD Concept: fundies:OperatingCashFlow Period: 1996-04-01 to 1997-03-31 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/818808/explain?concept=fundies%3AOperatingCashFlow&period=1997-03-31&surface=latest&period_type=duration&start=1996-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 0 USD (1996-04-01 to 1997-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818808/0001011034-98-000088.txt#1206 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
1998 1997-04-01 – 1998-03-31	−USD 6,957 Exact value Exact value: -6957 USD 1997-04-01 – 1998-03-31: -6957 USD Inspect Net Income Open source Share or cite Citation for Net Income · AMERIMMUNE PHARMACEUTICALS INC · 1998-03-31 AMERIMMUNE PHARMACEUTICALS INC (edgar:818808) Net Income: -6957 USD Concept: fundies:NetIncome Period: 1997-04-01 to 1998-03-31 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/818808/explain?concept=fundies%3ANetIncome&period=1998-03-31&surface=latest&period_type=duration&start=1997-04-01&unit=USD&dimensions= Input fundies:NetIncome: -6957 USD (1997-04-01 to 1998-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818808/0001011034-98-000088.txt#1201 The citation records this snapshot. The page link may show a newer release later.	−USD 5,461 Exact value Exact value: -5461 USD 1997-04-01 – 1998-03-31: -5461 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AMERIMMUNE PHARMACEUTICALS INC · 1998-03-31 AMERIMMUNE PHARMACEUTICALS INC (edgar:818808) Operating Cash Flow: -5461 USD Concept: fundies:OperatingCashFlow Period: 1997-04-01 to 1998-03-31 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/818808/explain?concept=fundies%3AOperatingCashFlow&period=1998-03-31&surface=latest&period_type=duration&start=1997-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5461 USD (1997-04-01 to 1998-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818808/0001011034-98-000088.txt#1206 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
1999 1998-04-01 – 1999-03-31	−USD 2.18 million Exact value Exact value: -2182657 USD 1998-04-01 – 1999-03-31: -2182657 USD Inspect Net Income Open source Share or cite Citation for Net Income · AMERIMMUNE PHARMACEUTICALS INC · 1999-03-31 AMERIMMUNE PHARMACEUTICALS INC (edgar:818808) Net Income: -2182657 USD Concept: fundies:NetIncome Period: 1998-04-01 to 1999-03-31 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/818808/explain?concept=fundies%3ANetIncome&period=1999-03-31&surface=latest&period_type=duration&start=1998-04-01&unit=USD&dimensions= Input fundies:NetIncome: -2182657 USD (1998-04-01 to 1999-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818808/0001017951-00-000156.txt#2041 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2000 1999-04-01 – 2000-03-31	−USD 1.92 million Exact value Exact value: -1922452 USD 1999-04-01 – 2000-03-31: -1922452 USD Inspect Net Income Open source Share or cite Citation for Net Income · AMERIMMUNE PHARMACEUTICALS INC · 2000-03-31 AMERIMMUNE PHARMACEUTICALS INC (edgar:818808) Net Income: -1922452 USD Concept: fundies:NetIncome Period: 1999-04-01 to 2000-03-31 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/818808/explain?concept=fundies%3ANetIncome&period=2000-03-31&surface=latest&period_type=duration&start=1999-04-01&unit=USD&dimensions= Input fundies:NetIncome: -1922452 USD (1999-04-01 to 2000-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818808/0001017951-01-500094.txt#2296 The citation records this snapshot. The page link may show a newer release later.	−USD 1.31 million Exact value Exact value: -1312083 USD 1999-04-01 – 2000-03-31: -1312083 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AMERIMMUNE PHARMACEUTICALS INC · 2000-03-31 AMERIMMUNE PHARMACEUTICALS INC (edgar:818808) Operating Cash Flow: -1312083 USD Concept: fundies:OperatingCashFlow Period: 1999-04-01 to 2000-03-31 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/818808/explain?concept=fundies%3AOperatingCashFlow&period=2000-03-31&surface=latest&period_type=duration&start=1999-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1312083 USD (1999-04-01 to 2000-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818808/0001017951-01-500094.txt#2327 The citation records this snapshot. The page link may show a newer release later.	USD 4,442 Exact value Exact value: 4442 USD 1999-04-01 – 2000-03-31: 4442 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AMERIMMUNE PHARMACEUTICALS INC · 2000-03-31 AMERIMMUNE PHARMACEUTICALS INC (edgar:818808) Capital Expenditure: 4442 USD Concept: fundies:CapitalExpenditure Period: 1999-04-01 to 2000-03-31 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/818808/explain?concept=fundies%3ACapitalExpenditure&period=2000-03-31&surface=latest&period_type=duration&start=1999-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4442 USD (1999-04-01 to 2000-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818808/0001017951-01-500094.txt#2333 The citation records this snapshot. The page link may show a newer release later.	−USD 1.32 million Calculation and evidence -1312083 − 4442 USD Exact free cash flow: -1316525 USD 1999-04-01 – 2000-03-31: -1312083 USD · Inspect Operating Cash Flow · Source 1999-04-01 – 2000-03-31: 4442 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AMERIMMUNE PHARMACEUTICALS INC · 2000-03-31 AMERIMMUNE PHARMACEUTICALS INC (edgar:818808) Free cash flow: -1316525 USD Concept: free-cash-flow Period: 1999-04-01 to 2000-03-31 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/818808?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1312083 USD (1999-04-01 to 2000-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818808/0001017951-01-500094.txt#2327 Input fundies:CapitalExpenditure: 4442 USD (1999-04-01 to 2000-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818808/0001017951-01-500094.txt#2333 The citation records this snapshot. The page link may show a newer release later.
2001 2000-04-01 – 2001-03-31	−USD 1.16 million Exact value Exact value: -1163809 USD 2000-04-01 – 2001-03-31: -1163809 USD Inspect Net Income Open source Share or cite Citation for Net Income · AMERIMMUNE PHARMACEUTICALS INC · 2001-03-31 AMERIMMUNE PHARMACEUTICALS INC (edgar:818808) Net Income: -1163809 USD Concept: fundies:NetIncome Period: 2000-04-01 to 2001-03-31 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/818808/explain?concept=fundies%3ANetIncome&period=2001-03-31&surface=latest&period_type=duration&start=2000-04-01&unit=USD&dimensions= Input fundies:NetIncome: -1163809 USD (2000-04-01 to 2001-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818808/0001017951-02-000322.txt#2569 The citation records this snapshot. The page link may show a newer release later.	−USD 924,733 Exact value Exact value: -924733 USD 2000-04-01 – 2001-03-31: -924733 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AMERIMMUNE PHARMACEUTICALS INC · 2001-03-31 AMERIMMUNE PHARMACEUTICALS INC (edgar:818808) Operating Cash Flow: -924733 USD Concept: fundies:OperatingCashFlow Period: 2000-04-01 to 2001-03-31 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/818808/explain?concept=fundies%3AOperatingCashFlow&period=2001-03-31&surface=latest&period_type=duration&start=2000-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -924733 USD (2000-04-01 to 2001-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818808/0001017951-02-000322.txt#2602 The citation records this snapshot. The page link may show a newer release later.	USD 466 Exact value Exact value: 466 USD 2000-04-01 – 2001-03-31: 466 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AMERIMMUNE PHARMACEUTICALS INC · 2001-03-31 AMERIMMUNE PHARMACEUTICALS INC (edgar:818808) Capital Expenditure: 466 USD Concept: fundies:CapitalExpenditure Period: 2000-04-01 to 2001-03-31 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/818808/explain?concept=fundies%3ACapitalExpenditure&period=2001-03-31&surface=latest&period_type=duration&start=2000-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 466 USD (2000-04-01 to 2001-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818808/0001017951-02-000322.txt#2607 The citation records this snapshot. The page link may show a newer release later.	−USD 925,199 Calculation and evidence -924733 − 466 USD Exact free cash flow: -925199 USD 2000-04-01 – 2001-03-31: -924733 USD · Inspect Operating Cash Flow · Source 2000-04-01 – 2001-03-31: 466 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AMERIMMUNE PHARMACEUTICALS INC · 2001-03-31 AMERIMMUNE PHARMACEUTICALS INC (edgar:818808) Free cash flow: -925199 USD Concept: free-cash-flow Period: 2000-04-01 to 2001-03-31 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/818808?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -924733 USD (2000-04-01 to 2001-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818808/0001017951-02-000322.txt#2602 Input fundies:CapitalExpenditure: 466 USD (2000-04-01 to 2001-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818808/0001017951-02-000322.txt#2607 The citation records this snapshot. The page link may show a newer release later.
2002 2001-04-01 – 2002-03-31	−USD 1.64 million Exact value Exact value: -1640622 USD 2001-04-01 – 2002-03-31: -1640622 USD Inspect Net Income Open source Share or cite Citation for Net Income · AMERIMMUNE PHARMACEUTICALS INC · 2002-03-31 AMERIMMUNE PHARMACEUTICALS INC (edgar:818808) Net Income: -1640622 USD Concept: fundies:NetIncome Period: 2001-04-01 to 2002-03-31 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/818808/explain?concept=fundies%3ANetIncome&period=2002-03-31&surface=latest&period_type=duration&start=2001-04-01&unit=USD&dimensions= Input fundies:NetIncome: -1640622 USD (2001-04-01 to 2002-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818808/0001017951-02-000322.txt#2569 The citation records this snapshot. The page link may show a newer release later.	−USD 864,562 Exact value Exact value: -864562 USD 2001-04-01 – 2002-03-31: -864562 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AMERIMMUNE PHARMACEUTICALS INC · 2002-03-31 AMERIMMUNE PHARMACEUTICALS INC (edgar:818808) Operating Cash Flow: -864562 USD Concept: fundies:OperatingCashFlow Period: 2001-04-01 to 2002-03-31 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/818808/explain?concept=fundies%3AOperatingCashFlow&period=2002-03-31&surface=latest&period_type=duration&start=2001-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -864562 USD (2001-04-01 to 2002-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818808/0001017951-02-000322.txt#2602 The citation records this snapshot. The page link may show a newer release later.	USD 1,006 Exact value Exact value: 1006 USD 2001-04-01 – 2002-03-31: 1006 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AMERIMMUNE PHARMACEUTICALS INC · 2002-03-31 AMERIMMUNE PHARMACEUTICALS INC (edgar:818808) Capital Expenditure: 1006 USD Concept: fundies:CapitalExpenditure Period: 2001-04-01 to 2002-03-31 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/818808/explain?concept=fundies%3ACapitalExpenditure&period=2002-03-31&surface=latest&period_type=duration&start=2001-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1006 USD (2001-04-01 to 2002-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818808/0001017951-02-000322.txt#2607 The citation records this snapshot. The page link may show a newer release later.	−USD 865,568 Calculation and evidence -864562 − 1006 USD Exact free cash flow: -865568 USD 2001-04-01 – 2002-03-31: -864562 USD · Inspect Operating Cash Flow · Source 2001-04-01 – 2002-03-31: 1006 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AMERIMMUNE PHARMACEUTICALS INC · 2002-03-31 AMERIMMUNE PHARMACEUTICALS INC (edgar:818808) Free cash flow: -865568 USD Concept: free-cash-flow Period: 2001-04-01 to 2002-03-31 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/818808?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -864562 USD (2001-04-01 to 2002-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818808/0001017951-02-000322.txt#2602 Input fundies:CapitalExpenditure: 1006 USD (2001-04-01 to 2002-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818808/0001017951-02-000322.txt#2607 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

24 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000818808, 818808, edgar:818808

Also known as VERSAILLES CAPITAL CORP /CO

AMERIMMUNE PHARMACEUTICALS INC

Latest quarter

Revenue

Operating cash flow

Trailing twelve months

Revenue

Capital expenditure

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

1998 1997-04-01 – 1998-03-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation